‌

US Patent 9913866 Selective cell targeting using adenovirus and chemical dimers

Patent 9913866 was granted and assigned to Salk Institute for Biological Studies on March, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Salk Institute for Biological Studies

0

Current Assignee

Salk Institute for Biological Studies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shigeki Miyake-Stoner0

Clodagh O'Shea0

Colin Powers0

Date of Patent

March 13, 2018

0

Patent Application Number

144854720

Date Filed

September 12, 2014

0

Patent Citations Received

US Patent 11708572 Acoustic cell separation techniques and processes

0

Patent Primary Examiner

0

Patent abstract

Compositions and methods for retargeting adenovirus to a cell using chemical dimers are described. In particular, a recombinant adenovirus comprising a nucleic acid comprising a capsid-dimerizing agent binder conjugate and a ligand-dimerizing agent binder conjugate is provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9913866 Selective cell targeting using adenovirus and chemical dimers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.